Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram.
暂无分享,去创建一个
Michael J Ackerman | Rickey E Carter | Paul A Friedman | Samuel J Asirvatham | Peter A Noseworthy | Zachi I Attia | P. Noseworthy | M. Ackerman | R. Carter | Z. Attia | P. Friedman | S. Asirvatham | Conner Galloway | J. Shreibati | D. Albert | A. Valys | D. Treiman | Frank Petterson | Vivek P. Gundotra | J. Dillon | Conner D Galloway | Alexander V Valys | Jacqueline B Shreibati | Daniel L Treiman | Frank L Petterson | Vivek P Gundotra | David E Albert | John J Dillon | M. Ackerman
[1] C. Slovis,et al. The ability of physicians to predict hyperkalemia from the ECG. , 1991, Annals of emergency medicine.
[2] Michael J Ackerman,et al. Noninvasive blood potassium measurement using signal-processed, single-lead ecg acquired from a handheld smartphone. , 2017, Journal of electrocardiology.
[3] E. Finkelstein,et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes , 2017, JAMA.
[4] K. Alexander,et al. Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG). , 2013, American heart journal.
[5] Deborah Silver,et al. Feature Visualization , 1994, Scientific Visualization.
[6] J. Wetmore,et al. Serum Potassium Levels and Mortality in Hemodialysis Patients: A Retrospective Cohort Study , 2016, American Journal of Nephrology.
[7] E. Peterson,et al. Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure. , 2015, JAMA.
[8] C. D'Orsi,et al. Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.
[9] G. Bakris,et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. , 2015, The New England journal of medicine.
[10] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[11] Michael J. Ackerman,et al. Novel Bloodless Potassium Determination Using a Signal‐Processed Single‐Lead ECG , 2016, Journal of the American Heart Association.
[12] D. Ransohoff,et al. Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.
[13] Bruce Kupelnick,et al. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .
[14] Lis Neubeck,et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. , 2013, International journal of cardiology.
[15] K. Bailey,et al. Errors of Classification With Potassium Blood Testing: The Variability and Repeatability of Critical Clinical Tests , 2018, Mayo Clinic proceedings.
[16] S. Aslam,et al. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] Americanjournalofkidneydisease. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Dennis A. Tighe,et al. Computer-assisted image processing 12 lead ECG model to diagnose hyperkalemia. , 2017, Journal of electrocardiology.
[19] P. Lavin,et al. Sodium zirconium cyclosilicate in hyperkalemia. , 2015, The New England journal of medicine.
[20] M. Sood,et al. Emergency management and commonly encountered outpatient scenarios in patients with hyperkalemia. , 2007, Mayo Clinic proceedings.
[21] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[22] C. Wingo,et al. Hyperkalemia: a potential silent killer. , 1998, Journal of the American Society of Nephrology : JASN.
[23] K. Fitch,et al. The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers. , 2017, American health & drug benefits.
[24] A. Laupacis,et al. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study , 2004 .
[25] M. Zhan,et al. The frequency of hyperkalemia and its significance in chronic kidney disease. , 2009, Archives of internal medicine.
[26] M. Raebel,et al. Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring , 2010, Journal of General Internal Medicine.
[27] K. Bhaskaran,et al. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study , 2017, BMJ Open.
[28] C. Kovesdy. Management of hyperkalaemia in chronic kidney disease , 2014, Nature Reviews Nephrology.
[29] Jesús Carlos Pedraza Ortega,et al. Location of mammograms ROI's and reduction of false-positive , 2017, Comput. Methods Programs Biomed..
[30] S. Brunelli,et al. Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function. , 2016, Clinical journal of the American Society of Nephrology : CJASN.
[31] J. Souverijn,et al. Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.
[32] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[33] B. Surawicz. Relationship between electrocardiogram and electrolytes. , 1967, American heart journal.
[34] Michael B. Gravenor,et al. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study , 2017, Circulation.